R162

CAS No. 64302-87-0

R162( R162 | R 162 | R-162 )

Catalog No. M17560 CAS No. 64302-87-0

R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 69 In Stock
10MG 123 In Stock
25MG 267 In Stock
50MG 428 In Stock
100MG 610 In Stock
500MG 1242 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    R162
  • Note
    Research use only, not for human use.
  • Brief Description
    R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.
  • Description
    R162 is an inhibitor of GDH activity and represses glioma cell growth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    R162 | R 162 | R-162
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    glutamate dehydrogenase 1 (GDH1)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    64302-87-0
  • Formula Weight
    264.28
  • Molecular Formula
    C17H12O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL; 378.39 mM
  • SMILES
    O=C(C1=C2C=CC=C1)C3=CC=C(CC=C)C(O)=C3C2=O
  • Chemical Name
    2-Allyl-1-hydroxy-anthraquinone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jin L, et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell. 2015 Feb 9;27(2):257-70.
molnova catalog
related products
  • PD173074

    PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src.

  • Sapitinib

    Sapitinib (AZD-8931, AZD8931) is a equipotent, reversible inhibitor of EGFR, ErbB2 and ErbB3 with IC50 of 4. 3 and 4 nM (phosphorylation inhibition), respectively.

  • PD153035 hydrochlori...

    PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.